NauseaAntineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantPostoperative Nausea and VomitingVomitingAntiemeticsTreatment OutcomeAntineoplastic AgentsCisplatinCombined Modality TherapyDoxorubicinCyclophosphamideDrug Administration ScheduleOndansetronDisease-Free SurvivalNeoadjuvant TherapyBreast NeoplasmsSurvival AnalysisNeoplasm StagingEtoposideSurvival RatePrognosisLung NeoplasmsNeoplasmsCarboplatinMethotrexatePaclitaxelFollow-Up StudiesVinblastineTime FactorsNeoplasm Recurrence, LocalGranisetronTaxoidsVomiting, AnticipatoryDeoxycytidineInduction ChemotherapyProspective StudiesAntimetabolites, AntineoplasticIfosfamideDrug Resistance, NeoplasmProchlorperazineInfusions, IntravenousMotion SicknessBleomycinSalvage TherapyMetoclopramideOrganoplatinum CompoundsAnthracyclinesNeutropeniaAntineoplastic Agents, AlkylatingNeoplasm MetastasisCarcinoma, Non-Small-Cell LungAcupressureCytarabineOvarian NeoplasmsDose-Response Relationship, DrugSerotonin 5-HT3 Receptor AntagonistsAdenocarcinomaClinical Trials as TopicChemotherapy, Cancer, Regional PerfusionAntineoplastic Agents, PhytogenicMorning SicknessTransplantation, AutologousRadiotherapyTesticular NeoplasmsDroperidolLymphoma, Non-HodgkinRadiotherapy, AdjuvantDouble-Blind MethodLeukopeniaCamptothecinColorectal NeoplasmsHodgkin DiseaseRecurrencePalliative CareKaplan-Meier EstimateAntibiotics, AntineoplasticDacarbazineDrug EvaluationQuality of LifeRandomized Controlled Trials as TopicBrain NeoplasmsBone NeoplasmsNeoplasms, Germ Cell and EmbryonalGranulocyte Colony-Stimulating FactorLiver NeoplasmsInfusions, Intra-ArterialFeasibility StudiesHyperemesis GravidarumAdministration, OralDexamethasoneStomach NeoplasmsPeritoneal NeoplasmsPlatinum CompoundsCarmustineMitomycinLomustineRadiotherapy DosageTegafurRisk Factors